X-linked agammaglobulinemia (XLA) is an X-linked inborn error of immunity caused by variants in the BTK gene. Variants in the 5’-untranslated region (UTR) of the BTK gene account for approximately 2% of all cases, but their detailed molecular pathogenesis remains unclear. In this study, we identified 5’-UTR variants in two XLA families and examined promoter activity. Whole-exome sequencing revealed the 5’-UTR variants (patient 1: c. -358-3G>T; patients 2 and 3: c. -356-6_-3del AAAG) in three patients from two families with XLA. Reduced BTK protein expression by flow cytometry and reduced mRNA expression by quantitative PCR were observed in all three patients. Quantitative PCR on nascent RNA identified a marked decrease in BTK transcriptional activity. Assay for transposase-accessible chromatin using sequencing (ATAC-seq) confirmed that the region near the variants adopts a closed chromatin structure. Chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR) results confirmed that the variants reduce the binding of the transcription factor PU.1. The 5’-UTR variants observed in these two families were identified as critical sites for PU.1 binding, suggesting that these sites are important for promoter activity. Further elucidation of the pathogenesis is anticipated through the accumulation of cases with variants in the 5’-UTR of the BTK gene.
Article navigation
4 June 2026
Meeting Abstract|
JSIAD Meeting Abstracts 2026|
June 04 2026
X-Linked Agammaglobulinemia with Variants in 5’-Untranslated Region
Yusuke Ishibashi,
Yusuke Ishibashi
1Department of Pediatrics and Developmental Biology, Institute of Science Tokyo Hospital
Search for other works by this author on:
Kay Tanita,
Kay Tanita
2Office of Global Affairs, Institute of Science Tokyo
Search for other works by this author on:
Takeshi Isoda,
Takeshi Isoda
1Department of Pediatrics and Developmental Biology, Institute of Science Tokyo Hospital
Search for other works by this author on:
Norimoto Kobayashi,
Norimoto Kobayashi
3Department of Pediatrics, Nagano Red Cross Hospital
Search for other works by this author on:
Kiyotaka Zaha,
Kiyotaka Zaha
4Department of Pediatrics, National Defense Medical College
Search for other works by this author on:
Shigeaki Nonoyama,
Shigeaki Nonoyama
4Department of Pediatrics, National Defense Medical College
Search for other works by this author on:
Kohsuke Imai,
Kohsuke Imai
4Department of Pediatrics, National Defense Medical College
Search for other works by this author on:
Masatoshi Takagi,
Masatoshi Takagi
1Department of Pediatrics and Developmental Biology, Institute of Science Tokyo Hospital
Search for other works by this author on:
Tomohiro Morio,
Tomohiro Morio
5Laboratory of Immunology and Molecular Medicine, Advanced Research Institute, Institute of Science Tokyo
Search for other works by this author on:
Hirokazu Kanegane
Hirokazu Kanegane
6Department of Child Health and Development, Graduate School of Medicine and Dental Science, Institute of Science Tokyo
Search for other works by this author on:
Yusuke Ishibashi
1Department of Pediatrics and Developmental Biology, Institute of Science Tokyo Hospital
Kay Tanita
2Office of Global Affairs, Institute of Science Tokyo
Takeshi Isoda
1Department of Pediatrics and Developmental Biology, Institute of Science Tokyo Hospital
Norimoto Kobayashi
3Department of Pediatrics, Nagano Red Cross Hospital
Kiyotaka Zaha
4Department of Pediatrics, National Defense Medical College
Shigeaki Nonoyama
4Department of Pediatrics, National Defense Medical College
Kohsuke Imai
4Department of Pediatrics, National Defense Medical College
Masatoshi Takagi
1Department of Pediatrics and Developmental Biology, Institute of Science Tokyo Hospital
Tomohiro Morio
5Laboratory of Immunology and Molecular Medicine, Advanced Research Institute, Institute of Science Tokyo
Hirokazu Kanegane
6Department of Child Health and Development, Graduate School of Medicine and Dental Science, Institute of Science Tokyo
© 2026 Ishibashi et al.
2025
Ishibashi et al.
This abstract is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by-nc-nd/4.0/).
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
J Hum Immun (2026) 2 (JSIAD2026): eJSIAD2026abstract.28.
Citation
Yusuke Ishibashi, Kay Tanita, Takeshi Isoda, Norimoto Kobayashi, Kiyotaka Zaha, Shigeaki Nonoyama, Kohsuke Imai, Masatoshi Takagi, Tomohiro Morio, Hirokazu Kanegane; X-Linked Agammaglobulinemia with Variants in 5’-Untranslated Region. J Hum Immun 4 June 2026; 2 (JSIAD2026): eJSIAD2026abstract.28. doi: https://doi.org/10.70962/JSIAD2026abstract.28
Download citation file:
0
Views
Suggested Content
Email alerts
Advertisement

